An observational study in Systemic Aspergillosis and Systemic Candidiasis, sponsored by University Children's Hospital Tuebingen. Completed at 1 site in Germany. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2009-12-29.
Sponsored by University Children's Hospital Tuebingen · Observational
Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.
265 studies on the registry are indexed under Candidiasis; 20 are open to participants now.
Browse Candidiasis studies →University Children's Hospital Tuebingen is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatric patients undergoing allogeneic stem cell transplantation
Exclusion Criteria:
This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Children's Hospital Tuebingen